Molecular cloning and characterization of the human A3 adenosine receptor.

The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. Br J Pharmacol (2013) 5.74

Nomenclature and classification of purinoceptors. Pharmacol Rev (1994) 5.32

International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update. Pharmacol Rev (2011) 4.16

Adenosine A3 receptor stimulation and cerebral ischemia. Eur J Pharmacol (1994) 2.33

2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors. J Med Chem (1994) 2.10

Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma. J Clin Invest (1995) 2.01

Pharmacological characterization of novel A3 adenosine receptor-selective antagonists. Neuropharmacology (1997) 1.86

N6-Substituted adenosine derivatives: selectivity, efficacy, and species differences at A3 adenosine receptors. Biochem Pharmacol (2003) 1.82

Adenosine A3 receptors: novel ligands and paradoxical effects. Trends Pharmacol Sci (1998) 1.79

Tissue distribution of adenosine receptor mRNAs in the rat. Br J Pharmacol (1996) 1.72

Gene dose-dependent atrial arrhythmias, heart block, and brady-cardiomyopathy in mice overexpressing A(3) adenosine receptors. Cardiovasc Res (2004) 1.60

Recent developments in adenosine receptor ligands and their potential as novel drugs. Biochim Biophys Acta (2010) 1.53

Inosine binds to A3 adenosine receptors and stimulates mast cell degranulation. J Clin Invest (1997) 1.47

Pharmacological and therapeutic effects of A3 adenosine receptor agonists. Drug Discov Today (2011) 1.44

Identification by site-directed mutagenesis of residues involved in ligand recognition and activation of the human A3 adenosine receptor. J Biol Chem (2002) 1.44

A3-adenosine receptors: design of selective ligands and therapeutic prospects. Drugs Future (1995) 1.41

Molecular Architecture of G Protein-Coupled Receptors. Drug Dev Res (1996) 1.39

Structure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists. J Med Chem (1998) 1.32

Induction of apoptosis in HL-60 human promyelocytic leukemia cells by adenosine A(3) receptor agonists. Biochem Biophys Res Commun (1996) 1.23

Role of the second extracellular loop of adenosine receptors in agonist and antagonist binding. Analysis of chimeric A1/A3 adenosine receptors. J Biol Chem (1994) 1.16

Adenosine receptors and cancer. Handb Exp Pharmacol (2009) 1.14

Structure-activity relationships of 9-alkyladenine and ribose-modified adenosine derivatives at rat A3 adenosine receptors. J Med Chem (1995) 1.06

Modulation of adenosine receptor affinity and intrinsic efficacy in adenine nucleosides substituted at the 2-position. Bioorg Med Chem (2004) 1.05

Regular alcohol consumption mimics cardiac preconditioning by protecting against ischemia-reperfusion injury. Proc Natl Acad Sci U S A (1997) 1.04

A3 adenosine receptors and mitogen-activated protein kinases in lung injury following in vivo reperfusion. Crit Care (2006) 1.03

2-triazole-substituted adenosines: a new class of selective A3 adenosine receptor agonists, partial agonists, and antagonists. J Med Chem (2006) 1.02

Ancient divergence of a complex family of immune-type receptor genes. Immunogenetics (2006) 1.00

Rational design of sulfonated A3 adenosine receptor-selective nucleosides as pharmacological tools to study chronic neuropathic pain. J Med Chem (2013) 0.96

Xanthines as adenosine receptor antagonists. Handb Exp Pharmacol (2011) 0.96

Relating surfactant properties to activity and solubilization of the human adenosine a3 receptor. Biophys J (2005) 0.93

Targeting of adenosine receptors in ischemia-reperfusion injury. Expert Opin Ther Targets (2010) 0.93

Insulin-increased L-arginine transport requires A(2A) adenosine receptors activation in human umbilical vein endothelium. PLoS One (2012) 0.91

A3 adenosine receptors in human astrocytoma cells: agonist-mediated desensitization, internalization, and down-regulation. Mol Pharmacol (2002) 0.91

Activation and Desensitization of Rat A3-Adenosine Receptors by Selective Adenosine Derivatives and Xanthine-7-Ribosides. Drug Dev Res (1998) 0.91

Translocation of arrestin induced by human A(3) adenosine receptor ligands in an engineered cell line: comparison with G protein-dependent pathways. Pharmacol Res (2008) 0.91

Adenosine A3 receptors on human eosinophils mediate inhibition of degranulation and superoxide anion release. Br J Pharmacol (1999) 0.91

Medicinal chemistry of the A3 adenosine receptor: agonists, antagonists, and receptor engineering. Handb Exp Pharmacol (2009) 0.87

Structure-activity relationships of 1,3-dialkylxanthine derivatives at rat A3 adenosine receptors. J Med Chem (1994) 0.86

A new drug design targeting the adenosinergic system for Huntington's disease. PLoS One (2011) 0.85

A functional screening of adenosine analogues at the adenosine A2B receptor: a search for potent agonists. Nucleosides Nucleotides (1998) 0.85

Bench-to-bedside review: adenosine receptors--promising targets in acute lung injury? Crit Care (2008) 0.85

Identification of A3 adenosine receptor agonists as novel non-narcotic analgesics. Br J Pharmacol (2016) 0.84

Activation of adenosine(1) (A(1)) receptors suppresses head shakes induced by a serotonergic hallucinogen in rats. Neuropharmacology (2009) 0.83

Adenosine A1 receptor activation attenuates lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg (2013) 0.83

Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors. Purinergic Signal (2015) 0.83

Pertussis toxin sensitive and insensitive effects of adenosine and carbachol in murine atria overexpressing A(1)-adenosine receptors. Br J Pharmacol (2003) 0.82

Exploring human adenosine A3 receptor complementarity and activity for adenosine analogues modified in the ribose and purine moiety. Bioorg Med Chem (2005) 0.82

Functionalized congeners of 1,4-dihydropyridines as antagonist molecular probes for A3 adenosine receptors. Bioconjug Chem (1999) 0.82

Adenosine, adenosine receptors and their role in glucose homeostasis and lipid metabolism. J Cell Physiol (2013) 0.81

Adenosine A3 receptor activation attenuates lung ischemia-reperfusion injury. Ann Thorac Surg (2013) 0.81

Engagement of the GABA to KCC2 signaling pathway contributes to the analgesic effects of A3AR agonists in neuropathic pain. J Neurosci (2015) 0.81

Ligand-, structure- and pharmacophore-based molecular fingerprints: a case study on adenosine A(1), A (2A), A (2B), and A (3) receptor antagonists. J Comput Aided Mol Des (2012) 0.80

Synthesis and pharmacological characterization of a new series of 5,7-disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazine derivatives as adenosine receptor antagonists: A preliminary inspection of ligand-receptor recognition process. Bioorg Med Chem (2010) 0.80

Functional studies in atrium overexpressing A1-adenosine receptors. Br J Pharmacol (1999) 0.79

A positive inotropic effect of adenosine in cardiac preparations of right atria from diseased human hearts. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.78

Adenosine A1 receptor-mediated changes in basal and histamine-stimulated levels of intracellular calcium in primary rat astrocytes. Br J Pharmacol (1995) 0.78

Failure of CGS15943A to block the hypotensive action of agonists acting at the adenosine A3 receptor. Br J Pharmacol (1994) 0.77

Identification and function of adenosine A3 receptor in afferent arterioles. Am J Physiol Renal Physiol (2015) 0.77

Adenosine and ischemic preconditioning. Curr Pharm Des (1999) 0.77

Isolation and characterization of an avian A1 adenosine receptor gene and a related cDNA clone. Biochem J (1995) 0.76

Chapter 13. A3 Adenosine Receptors. Annu Rep Med Chem (1) 0.75

Investigation of cholecystokinin receptors in the human lower esophageal sphincter. World J Gastroenterol (2014) 0.75

Photomodulation of G protein-coupled adenosine receptors by a novel light-switchable ligand. Bioconjug Chem (2014) 0.75

Attenuation of Pulmonary Ischemia-Reperfusion Injury by Adenosine A2B Receptor Antagonism. Ann Thorac Surg (2016) 0.75

DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54

A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem (1983) 206.01

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol (1973) 47.81

Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J Neurochem (1979) 5.92

Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. Mol Pharmacol (1986) 4.15

Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor. Proc Natl Acad Sci U S A (1992) 3.91

A practical computer-based approach to the analysis of radioligand binding experiments. Comput Programs Biomed (1984) 3.68

Drug antagonism and pAx. Pharmacol Rev (1957) 3.12

Palmitoylation of the human beta 2-adrenergic receptor. Mutation of Cys341 in the carboxyl tail leads to an uncoupled nonpalmitoylated form of the receptor. J Biol Chem (1989) 2.95

G-protein alpha-subunit expression, myristoylation, and membrane association in COS cells. Proc Natl Acad Sci U S A (1990) 2.13

Adenosine A3 receptors mediate hypotension in the angiotensin II-supported circulation of the pithed rat. Br J Pharmacol (1993) 1.78

Structure/function relationship of proteins belonging to the family of receptors coupled to GTP-binding proteins. Eur J Biochem (1991) 1.74

Molecular cloning and expression of the cDNA for a novel A2-adenosine receptor subtype. Mol Endocrinol (1992) 1.55

Molecular cloning of a novel putative G-protein coupled receptor expressed during rat spermiogenesis. FEBS Lett (1991) 1.53

Adenosine-induced bronchoconstriction in asthma. Antagonism by inhaled theophylline. Am Rev Respir Dis (1984) 1.52

Cloning and expression of an A1 adenosine receptor from rat brain. Mol Pharmacol (1991) 1.51

Molecular cloning and expression of an adenosine A2b receptor from human brain. Biochem Biophys Res Commun (1992) 1.24

Autoreceptor-mediated purinergic and cholinergic inhibition of motor nerve terminal calcium currents in the rat. J Physiol (1991) 1.19

Molecular characterization of a human brain adenosine A2 receptor. Brain Res Mol Brain Res (1992) 1.10

Distribution of adenosine A2 receptor mRNA in the human brain. Neurosci Lett (1991) 1.08

Binding of the adenosine A2 receptor ligand [3H]CGS 21680 to human and rat brain: evidence for multiple affinity sites. J Neurochem (1990) 1.07

Cloning and functional characterization of a human A1 adenosine receptor. Biochem Biophys Res Commun (1992) 1.06

[125I]Aminobenzyladenosine, a new radioligand with improved specific binding to adenosine receptors in heart. Circ Res (1985) 0.98

125I-labeled 8-phenylxanthine derivatives: antagonist radioligands for adenosine A1 receptors. J Med Chem (1988) 0.98

A steric and electrostatic comparison of three models for the agonist/antagonist binding site on the adenosine A1 receptor. J Med Chem (1992) 0.93

A novel synthesis of xanthines: support for a new binding mode for xanthines with respect to adenosine at adenosine receptors. J Med Chem (1990) 0.89

Adenosine does not mediate the pulmonary vasodilator response of adenosine 5'-triphosphate in the feline pulmonary vascular bed. J Pharmacol Exp Ther (1989) 0.86

Adenosine receptors in post-mortem human cerebral cortex and the effect of carbamazepine. Clin Exp Pharmacol Physiol (1986) 0.83

Adenosine is a pulmonary vasodilator in newborn lambs. Am Rev Respir Dis (1992) 0.82

International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev (2001) 9.90

Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med (1991) 3.02

Phosphorylation of connexin43 on serine368 by protein kinase C regulates gap junctional communication. J Cell Biol (2000) 2.78

Properties and regulation of gap junctional hemichannels in the plasma membranes of cultured cells. J Cell Biol (1996) 2.47

Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells. J Biol Chem (2000) 2.44

Inhibition of gap junction and adherens junction assembly by connexin and A-CAM antibodies. J Cell Biol (1992) 2.30

Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco community prophylaxis trial. N Engl J Med (1990) 2.29

Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1. Nat Med (1998) 2.27

Accuracy of transesophageal echocardiography for identifying left atrial thrombi. A prospective, intraoperative study. Ann Intern Med (1995) 2.27

The cardiac effects of adenosine. Prog Cardiovasc Dis (1989) 2.20

Internal pH of isolated chromaffin vesicles. J Biol Chem (1976) 2.00

Junctions between cancer cells in culture: ultrastructure and permeability. Science (1971) 1.98

The misunderstood Spanish-speaking patient. Am J Psychiatry (1980) 1.85

Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis. Am J Ophthalmol (1998) 1.83

Lymphocyte subset reference ranges in adult Caucasians. Clin Immunol Immunopathol (1991) 1.79

Echocardiographic predictors of left ventricular outflow tract obstruction and systolic anterior motion of the mitral valve after mitral valve reconstruction for myxomatous valve disease. J Am Coll Cardiol (1999) 1.75

Canine mast cell adenosine receptors: cloning and expression of the A3 receptor and evidence that degranulation is mediated by the A2B receptor. Mol Pharmacol (1997) 1.74

A(2A) adenosine receptor-mediated inhibition of renal injury and neutrophil adhesion. Am J Physiol Renal Physiol (2000) 1.71

Rapid and reversible reduction of junctional permeability in cells infected with a temperature-sensitive mutant of avian sarcoma virus. J Cell Biol (1981) 1.67

Ion permeability of isolated chromaffin granules. J Gen Physiol (1976) 1.65

Non-specificity of anti-HCV test for seroepidemiological analysis. Lancet (1990) 1.62

Selective A2A adenosine receptor activation reduces ischemia-reperfusion injury in rat kidney. Am J Physiol (1999) 1.61

Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system. J Comp Neurol (1998) 1.55

Mycobacterium avium complex in the respiratory or gastrointestinal tract and the risk of M. avium complex bacteremia in patients with human immunodeficiency virus infection. J Infect Dis (1994) 1.53

Ischemic colitis in a young adult patient: report of a case. Dis Colon Rectum (1974) 1.53

Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists. Br J Pharmacol (2001) 1.53

Patterns of A2A extracellular adenosine receptor expression in different functional subsets of human peripheral T cells. Flow cytometry studies with anti-A2A receptor monoclonal antibodies. Mol Pharmacol (1999) 1.51

Neointimal thickening after severe coronary artery injury is limited by a short-term administration of a factor Xa inhibitor. Results in a porcine model. Circulation (1996) 1.50

Gene dose effect reveals no Gs-coupled A2A adenosine receptor reserve in murine T-lymphocytes: studies of cells from A2A-receptor-gene-deficient mice. Biochem J (2001) 1.49

Effect of foscarnet therapy on human immunodeficiency virus p24 antigen levels in AIDS patients with cytomegalovirus retinitis. J Infect Dis (1992) 1.49

Alpha 1-acid glycoprotein levels in AIDS patients before and after short-term treatment with zidovudine (ZDV) J Acquir Immune Defic Syndr (1993) 1.48

Inosine binds to A3 adenosine receptors and stimulates mast cell degranulation. J Clin Invest (1997) 1.47

Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A(2B) adenosine receptors. J Med Chem (2000) 1.44

Blood and albumin cardioplegia preserve endothelium-dependent microvascular responses. Ann Thorac Surg (1993) 1.41

Transgenic A1 adenosine receptor overexpression increases myocardial resistance to ischemia. Proc Natl Acad Sci U S A (1997) 1.41

Adenosine and inosine increase cutaneous vasopermeability by activating A(3) receptors on mast cells. J Clin Invest (2000) 1.40

Molecular cloning and functional expression of a sheep A3 adenosine receptor with widespread tissue distribution. Mol Pharmacol (1993) 1.40

Case 6--1999. Off-pump coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth (1999) 1.39

Repair of sternal dehiscence using a Harrington compression system. Ann Thorac Surg (1988) 1.39

A2B adenosine and P2Y2 receptors stimulate mitogen-activated protein kinase in human embryonic kidney-293 cells. cross-talk between cyclic AMP and protein kinase c pathways. J Biol Chem (1999) 1.38

The "H" graft: an alternative approach for performing minimally invasive direct coronary artery bypass. J Thorac Cardiovasc Surg (1998) 1.38

Ser364 of connexin43 and the upregulation of gap junction assembly by cAMP. J Cell Biol (2001) 1.37

Blockade of adenosine A2B receptors ameliorates murine colitis. Br J Pharmacol (2008) 1.35

Home-based factor infusion therapy and hospitalization for bleeding complications among males with haemophilia. Haemophilia (2001) 1.33

The internal pH of mast cell granules. FEBS Lett (1980) 1.31

The role of inflammation in vascular diseases. J Leukoc Biol (2000) 1.30

Adenosine A3 receptor expression and function in eosinophils. Am J Respir Cell Mol Biol (1997) 1.28

Dallas discogram description. A new classification of CT/discography in low-back disorders. Spine (Phila Pa 1976) (1987) 1.27

[3H]MRS 1754, a selective antagonist radioligand for A(2B) adenosine receptors. Biochem Pharmacol (2001) 1.25

Cyclic AMP and LDL trigger a rapid enhancement in gap junction assembly through a stimulation of connexin trafficking. J Cell Sci (2000) 1.24

Lung lamellar bodies maintain an acidic internal pH. J Biol Chem (1986) 1.23

Postirradiation atrophic changes of bone and related complications. Radiology (1975) 1.23

Biological amine transport in chromaffin ghosts. Coupling to the transmembrane proton and potential gradients. J Biol Chem (1979) 1.22

Antagonists of the receptor-G protein interface block Gi-coupled signal transduction. J Biol Chem (1998) 1.22

Chicken embryo lens cultures mimic differentiation in the lens. Dev Biol (1984) 1.22

Adenosine A(2A) receptor stimulation reduces inflammation and neointimal growth in a murine carotid ligation model. Arterioscler Thromb Vasc Biol (2001) 1.21

Enhanced protection from renal ischemia-reperfusion [correction of ischemia:reperfusion] injury with A(2A)-adenosine receptor activation and PDE 4 inhibition. Kidney Int (2001) 1.20

Ultrastructural localization of adenosine A2A receptors suggests multiple cellular sites for modulation of GABAergic neurons in rat striatum. J Comp Neurol (2001) 1.20

Protonmotive force and catecholamine transport in isolated chromaffin granules. J Biol Chem (1979) 1.18

Neutrophil A2A adenosine receptor inhibits inflammation in a rat model of meningitis: synergy with the type IV phosphodiesterase inhibitor, rolipram. J Infect Dis (1999) 1.18

Targeted deletion of the A3 adenosine receptor confers resistance to myocardial ischemic injury and does not prevent early preconditioning. J Mol Cell Cardiol (2001) 1.17

Detection of antibodies to hepatitis C virus in U.S. blood donors. J Clin Microbiol (1991) 1.17

Solution structure of the cytoplasmic domain of phopholamban: phosphorylation leads to a local perturbation in secondary structure. Biochemistry (1995) 1.16

Calculating the dissociation constant of an unlabeled compound from the concentration required to displace radiolabel binding by 50%. J Cyclic Nucleotide Res (1982) 1.16

Extracellular action of adenosine and the antagonism by aminophylline on the atrioventricular conduction of isolated perfused guinea pig and rat hearts. Circ Res (1982) 1.15

A1 adenosine receptors. Two amino acids are responsible for species differences in ligand recognition. J Biol Chem (1994) 1.14

Invasive fungal sinusitis and meningitis due to Arthrographis kalrae in a patient with AIDS. J Clin Microbiol (2001) 1.14

Projecting the medical costs of AIDS and ARC in the United States. J Acquir Immune Defic Syndr (1988) 1.14

Adenosine-induced vasoconstriction in vivo. Role of the mast cell and A3 adenosine receptor. Circ Res (1996) 1.14

Pharmacokinetics of intermittently administered intravenous foscarnet in the treatment of acquired immunodeficiency syndrome patients with serious cytomegalovirus retinitis. Antimicrob Agents Chemother (1989) 1.13

Relationship between plasma concentrations of 3'-deoxy-3'-fluorothymidine (alovudine) and antiretroviral activity in two concentration-controlled trials. J Infect Dis (1994) 1.13

Regulation of GH3-cell function via adenosine A1 receptors. Inhibition of prolactin release, cyclic AMP production and inositol phosphate generation. Biochem J (1988) 1.12

Design, synthesis, and evaluation of novel A2A adenosine receptor agonists. J Med Chem (2001) 1.12

A3 adenosine receptor activation triggers phosphorylation of protein kinase B and protects rat basophilic leukemia 2H3 mast cells from apoptosis. Mol Pharmacol (2001) 1.12

Interaction of cardiotonic thiadiazinone derivatives with cardiac troponin C. J Biol Chem (1996) 1.12

A cluster of transfusion-associated babesiosis cases traced to a single asymptomatic donor. JAMA (1999) 1.11

Cloned receptors and cardiovascular responses to adenosine. Cardiovasc Res (1993) 1.11

deltapH and catecholamine distribution in isolated chromaffin granules. J Biol Chem (1978) 1.11

The impact of foodborne calicivirus disease: the Minnesota experience. J Infect Dis (2000) 1.11

Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA. Arch Intern Med (1998) 1.09

The internal pH of isolated serotonin containing granules of pig platelets. J Biol Chem (1978) 1.09

Foscarnet therapy for severe acyclovir-resistant herpes simplex virus type-2 infections in patients with the acquired immunodeficiency syndrome (AIDS). An uncontrolled trial. Ann Intern Med (1989) 1.08

Production of complement by spleen cells in vitro and its possible role in an allograft rejection model. Nature (1968) 1.08

Nucleoside-induced arteriolar constriction: a mast cell-dependent response. Am J Physiol (1994) 1.08

A lens intercellular junction protein, MP26, is a phosphoprotein. J Cell Biol (1986) 1.07

Quantitative analysis of low-resistance junctions between cultured cells and correlation with gap-junctional areas. J Cell Biol (1978) 1.07

Junctions between lens fiber cells are labeled with a monoclonal antibody shown to be specific for MP26. J Cell Biol (1985) 1.07

Characterization of two affinity states of adenosine A2a receptors with a new radioligand, 2-[2-(4-amino-3-[125I]iodophenyl)ethylamino]adenosine. Mol Pharmacol (1995) 1.06

Double tagging recombinant A1- and A2A-adenosine receptors with hexahistidine and the FLAG epitope. Development of an efficient generic protein purification procedure. Biochem Pharmacol (1996) 1.06

The role of glutaraldehyde-induced cross-links in calcification of bovine pericardium used in cardiac valve bioprostheses. Am J Pathol (1987) 1.06

Pharmacokinetic, safety, and antiviral profiles of oral ganciclovir in persons infected with human immunodeficiency virus: a phase I/II study. AIDS Clinical Trials Group, and Cytomegalovirus Cooperative Study Group. J Infect Dis (1995) 1.06

Formation of low-resistance junctions in vitro in the absence of protein synthesis and ATP production. Exp Cell Res (1977) 1.05

Effect of novel A2A adenosine receptor agonist ATL 313 on Clostridium difficile toxin A-induced murine ileal enteritis. Infect Immun (2006) 1.05

Decline in the rate of specific opportunistic infections at San Francisco General Hospital, 1994-1997. AIDS (1998) 1.04

Receptors that inhibit phosphoinositide breakdown. Trends Pharmacol Sci (1989) 1.04

Selective adenosine-A2A activation reduces lung reperfusion injury following transplantation. J Heart Lung Transplant (1999) 1.03

Sequence of a cDNA encoding the platelet aggregation inhibitor trigramin. Nucleic Acids Res (1990) 1.03

Anterior lumbar interbody fusion. Spine (Phila Pa 1976) (1988) 1.03